Macau, China vs Sri Lanka: HIV-positive TB patients on ART (antiretroviral therapy)
Macau, China
100.0%
in 2024
Sri Lanka
100.0%
in 2024
Macau, China rank
1st
Sri Lanka rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Macau, China
- Sri Lanka
How they compare
Macau, China currently reports 100.0% against 100.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 5 times across 17 shared years of data; in 2003 it was Macau, China ahead.
Macau, China ranks 1st and Sri Lanka ranks 1st of 144 countries.
Across the 3 decades both report, Macau, China averaged higher in 1 and Sri Lanka in 2.
Head to head by decade
| Decade | Macau, China | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 58.3% | 83.3% | 25.0% | Sri Lanka |
| 2010s | 65.3% | 79.3% | 14.0% | Sri Lanka |
| 2020s | 78.4% | 67.0% | 11.4% | Macau, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Macau, China or Sri Lanka?
- Macau, China, at 100.0% against 100.0% in Sri Lanka as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Macau, China and Sri Lanka?
- 0.0%, with Macau, China ahead.
- How many years of comparable data are there for Macau, China and Sri Lanka?
- 17 years are reported by both, from 2003 to 2024.
- How do Macau, China and Sri Lanka rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Macau, China ranks 1st and Sri Lanka ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.